Testosterone is the primary male sex hormone, produced mainly in the testicles, playing crucial roles throughout a man’s life. During fetal development, testosterone drives formation of male reproductive organs. At puberty, it causes voice deepening, muscle development, facial and body hair growth, and sexual maturation. Throughout adulthood, testosterone maintains muscle mass and strength, bone density, sexual function and libido, sperm production, energy and mood, and metabolic health. Far from being solely a “sex hormone,” testosterone influences virtually every organ system.

Low testosterone, medically termed hypogonadism, occurs when the testes produce insufficient testosterone. This condition affects approximately 20-40% of men over age 45, with prevalence increasing steadily with aging—by age 80, roughly 50% of men have testosterone levels below normal range. However, low testosterone isn’t just an “aging issue.” Younger men increasingly experience low testosterone due to obesity, metabolic syndrome, type 2 diabetes, certain medications, and other factors. Concerningly, average testosterone levels have declined 15-20% in recent decades across all age groups.

Symptoms extend well beyond sexual function. While decreased libido and erectile dysfunction are common, low testosterone also causes persistent fatigue, reduced muscle mass and strength, increased body fat (particularly abdominal), mood changes including depression and irritability, cognitive difficulties, and reduced bone density. These symptoms develop gradually, often dismissed as “normal aging” when they represent treatable hormone deficiency.

What makes low testosterone particularly important is its bidirectional relationship with metabolic disease. Low testosterone increases risk for obesity, type 2 diabetes, metabolic syndrome, and cardiovascular disease. Simultaneously, these metabolic conditions lower testosterone, creating vicious cycles. Men with type 2 diabetes have 2-3 times higher rates of low testosterone. Obesity and low testosterone reinforce each other—low testosterone promotes fat accumulation (particularly visceral abdominal fat), while obesity suppresses testosterone production.

Fortunately, low testosterone is readily diagnosed through blood testing and highly treatable. Testosterone replacement therapy, available in multiple formulations (injections, gels, patches, pellets), effectively restores normal testosterone levels, reverses symptoms, and may improve metabolic health. With proper management, most men with low testosterone experience dramatic improvements in energy, mood, sexual function, body composition, and overall quality of life.

Quick Summary:

• Low testosterone (hypogonadism) affects 20-40% of men over 45, with prevalence reaching 50% by age 80
• Testosterone levels have declined 15-20% over recent decades across all age groups, independent of aging
• Classic symptoms include low libido, erectile dysfunction, fatigue, reduced muscle mass, increased body fat, mood changes, cognitive difficulties
• Low testosterone dramatically increases metabolic disease risk: 2-3x higher diabetes risk, increased metabolic syndrome, obesity, cardiovascular disease
• Bidirectional relationship with obesity: low testosterone promotes fat gain, obesity suppresses testosterone production
• Blood testing is essential: total testosterone <300 ng/dL on two morning tests indicates low testosterone; free testosterone and SHBG provide additional information
• Multiple causes including aging, obesity, type 2 diabetes, medications, pituitary disorders, testicular damage, and genetic conditions
• Testosterone replacement therapy (TRT) is highly effective for true hypogonadism, improving symptoms in 80-90% of men
• TRT options include injections, topical gels, patches, pellets, and oral preparations—each with advantages/disadvantages
• Natural testosterone optimization through weight loss, exercise (particularly resistance training), sleep improvement, and stress reduction can raise levels 10-30%
• Monitoring during TRT is essential: regular blood tests, prostate examination, hematocrit checks preventing complications
• Controversial issues: testosterone and prostate cancer (likely not causative), cardiovascular effects (data mixed), use in aging men with borderline low levels

---

What Is Testosterone and What Does It Do?

Testosterone is a steroid hormone belonging to the androgen family, produced primarily (95%) in Leydig cells of the testes, with small amounts (5%) produced in adrenal glands. Women also produce testosterone in ovaries and adrenal glands, though at much lower levels (about 5-10% of male levels). In men, normal testosterone production is 4-7 mg daily, declining approximately 1-2% annually after age 30-40.

Testosterone Production and Regulation

Testosterone production is regulated by the hypothalamic-pituitary-gonadal (HPG) axis:

1. Hypothalamus (brain region) produces gonadotropin-releasing hormone (GnRH) in pulsatile fashion
2. GnRH stimulates the pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
3. LH stimulates Leydig cells in testes to produce testosterone
4. FSH stimulates sperm production in testes
5. Testosterone provides negative feedback to hypothalamus and pituitary—when testosterone is adequate, GnRH and LH production decrease; when low, they increase

This feedback loop maintains relatively stable testosterone levels. Disruption at any level—hypothalamus, pituitary, or testes—can cause low testosterone.

Forms of Testosterone in Blood

Testosterone circulates in three forms:

Free Testosterone (2-3% of total):

Unbound testosterone, biologically active, able to enter cells and exert effects. This is the “active” form, though it represents only a small fraction of total testosterone.

Albumin-Bound Testosterone (50-60% of total):

Loosely bound to albumin protein. This binding is weak enough that albumin-bound testosterone can readily dissociate and become biologically available. Free testosterone plus albumin-bound testosterone equals “bioavailable testosterone.”

SHBG-Bound Testosterone (40-45% of total):

Tightly bound to sex hormone-binding globulin (SHBG), not biologically available. SHBG binds testosterone so strongly that it cannot dissociate to exert effects.

Total testosterone measures all three forms. However, SHBG levels vary based on age (increases with age), obesity (decreases), liver disease, thyroid function, and other factors. When SHBG is high, total testosterone can be normal but free testosterone low (symptomatic). When SHBG is low (obesity, metabolic syndrome), total testosterone may be low but free testosterone normal (often asymptomatic). This is why measuring free testosterone or calculating it from total testosterone and SHBG provides a more accurate picture of testosterone status than total testosterone alone.

Functions of Testosterone

Sexual Function and Libido:

Testosterone drives sexual desire (libido) in men and is essential for normal erectile function, though erections require multiple other factors (healthy blood vessels, nerve function, psychological wellbeing). Low testosterone causes decreased libido in virtually all affected men and contributes to erectile dysfunction in many, though not all men with erectile dysfunction have low testosterone.

Muscle Mass and Strength:

Testosterone is powerfully anabolic—it stimulates muscle protein synthesis, increases muscle fiber size, and enhances muscle strength. This is why exogenous testosterone (and anabolic steroids, which are synthetic testosterone derivatives) cause dramatic muscle gains. Low testosterone causes gradual muscle loss, reduced strength, and difficulty maintaining muscle despite exercise.

Bone Density:

Testosterone is essential for bone formation and maintaining bone mineral density. Low testosterone increases bone resorption (breakdown) while decreasing bone formation, causing osteopenia and osteoporosis. Osteoporosis in men is often related to low testosterone, increasing fracture risk, particularly vertebral and hip fractures.

Fat Distribution:

Testosterone influences where the body stores fat. Adequate testosterone promotes lean body composition. Low testosterone causes increased body fat, particularly visceral (abdominal) fat, creating “central obesity” with health risks exceeding subcutaneous fat.

Red Blood Cell Production:

Testosterone stimulates erythropoietin production in kidneys and directly stimulates bone marrow to produce red blood cells. Low testosterone can cause mild anemia, while testosterone replacement increases hemoglobin and hematocrit (sometimes excessively, requiring monitoring).

Mood and Energy:

Testosterone influences multiple neurotransmitter systems affecting mood, motivation, and energy. Low testosterone commonly causes fatigue, low energy, reduced motivation, irritability, and depression. The relationship is complex—testosterone deficiency can cause depression, and depression can lower testosterone.

Cognitive Function:

Testosterone receptors exist throughout the brain. Testosterone appears to support verbal memory, spatial abilities, and processing speed. Low testosterone is associated with cognitive difficulties, though whether testosterone replacement improves cognition remains debated.

Metabolic Health:

Testosterone promotes insulin sensitivity, healthy lipid profiles (higher HDL, lower triglycerides), and metabolic health. Low testosterone impairs glucose metabolism, increases insulin resistance, and contributes to metabolic syndrome and type 2 diabetes development.

---

Symptoms of Low Testosterone

Low testosterone symptoms develop gradually, often over years, and are frequently dismissed as “normal aging” or attributed to stress, depression, or other factors. Symptom severity doesn’t always correlate with testosterone level—some men with moderately low testosterone have severe symptoms, while others with very low levels have few complaints.

Sexual Symptoms

Decreased Libido:

Reduced or absent sexual desire, loss of interest in sex. This is the most common and specific symptom of low testosterone, present in 60-80% of men with hypogonadism. However, decreased libido has many causes beyond low testosterone (relationship issues, stress, depression, medications), so it’s not diagnostic alone.

Erectile Dysfunction:

Difficulty achieving or maintaining erections adequate for sexual activity. Low testosterone contributes to ED in many men, but ED more commonly results from vascular disease, diabetes, medications, or psychological factors. An estimated 10-35% of men with ED have low testosterone. Importantly, men with low testosterone but normal vascular function typically maintain early morning erections, distinguishing hormonal from vascular ED.

Reduced Spontaneous Erections:

Fewer morning erections or nocturnal erections. Healthy men experience 3-5 erections during REM sleep; these decline with low testosterone.

Infertility:

Low sperm count or poor sperm quality, as testosterone is essential for spermatogenesis (sperm production). However, many men with low testosterone maintain adequate sperm production through local testicular testosterone concentrations higher than blood levels.

Physical Symptoms

Fatigue and Low Energy:

Persistent tiredness despite adequate sleep, lack of energy for daily activities, reduced stamina, needing more rest. This is extremely common (70-80% of men with low testosterone) but nonspecific—countless conditions cause fatigue. However, when fatigue accompanies other testosterone deficiency symptoms, particularly sexual symptoms and body composition changes, low testosterone should be considered.

Reduced Muscle Mass and Strength:

Loss of muscle, difficulty building or maintaining muscle despite resistance exercise, decreased strength, reduced exercise capacity. The loss is gradual—muscle doesn’t disappear suddenly but steadily declines over months to years.

Increased Body Fat:

Weight gain, particularly abdominal fat, increased breast tissue (gynecomastia in some men), overall change toward less lean, more fat body composition. The visceral fat accumulation worsens insulin resistance and creates cardiovascular risk.

Reduced Bone Density:

Not symptomatic until fractures occur. Low testosterone over years causes osteoporosis, increasing fracture risk particularly in spine, hips, and wrists. Osteoporosis is under-recognized in men, often not screened for, but accounts for 30% of hip fractures.

Hot Flashes:

Some men with severely low or suddenly declining testosterone (from orchiectomy or medication-induced) experience hot flashes similar to menopausal women. This is less common with gradually developing low testosterone.

Psychological and Cognitive Symptoms

Depression:

Low mood, loss of interest in activities, feeling down or hopeless, reduced pleasure in life. Depression rates are significantly higher in men with low testosterone. The relationship is bidirectional—low testosterone can cause depression, and major depression can suppress testosterone. Distinguishing primary depression from testosterone-related mood symptoms can be challenging.

Irritability and Mood Changes:

Increased irritability, short temper, emotional lability, feeling “on edge.” These changes are often subtle and attributed to stress or “just getting older.”

Reduced Motivation and Drive:

Decreased ambition, reduced competitiveness, loss of drive that characterized earlier years, passivity. This symptom is subjective but reported by many men and concerning to them.

Difficulty Concentrating:

“Brain fog,” difficulty focusing on tasks, reduced mental sharpness, memory problems. These cognitive symptoms are common complaints but difficult to measure objectively.

Sleep Disturbances:

Difficulty falling asleep, frequent nighttime awakening, non-restorative sleep. Low testosterone may contribute to sleep apnea, which itself lowers testosterone.

Metabolic and Cardiovascular Effects

Low testosterone increases risk for:

Type 2 Diabetes: Men with low testosterone have 2-3 times higher diabetes risk. Approximately 30-40% of men with type 2 diabetes have low testosterone.

Metabolic Syndrome: The cluster of abdominal obesity, high blood pressure, elevated triglycerides, low HDL cholesterol, and elevated fasting glucose. Low testosterone is strongly associated with metabolic syndrome.

Cardiovascular Disease: Low testosterone correlates with increased cardiovascular disease risk in observational studies, though causation isn’t definitively proven. Proposed mechanisms include worsening metabolic health, increasing visceral fat, promoting insulin resistance, and unfavorable lipid changes.

Anemia: Mild normochromic, normocytic anemia from reduced red blood cell production.

---

Causes of Low Testosterone

Low testosterone has numerous causes, categorized as primary hypogonadism (testicular failure), secondary hypogonadism (hypothalamic or pituitary dysfunction), or mixed.

Primary Hypogonadism (Testicular Failure)

The testes fail to produce adequate testosterone despite normal or elevated LH. Causes include:

Aging (Late-Onset Hypogonadism):

Testosterone declines approximately 1-2% annually after age 30-40. Not all men develop symptomatic low testosterone with aging—wide variation exists. Some 80-year-olds maintain normal testosterone; others have low levels by age 50. Factors influencing age-related decline include genetics, overall health, obesity, medications, and comorbidities.

Klinefelter Syndrome:

A genetic condition (47,XXY karyotype instead of normal 46,XY) where men have an extra X chromosome, causing small, firm testes, severely impaired testosterone production, infertility, tall stature, gynecomastia, and reduced body hair. Affects approximately 1 in 500-1,000 males, often diagnosed in adolescence when puberty doesn’t progress or during infertility workup.

Undescended Testes (Cryptorchidism):

If testes don’t descend into scrotum during development and aren’t surgically corrected, testicular damage occurs, impairing testosterone production and fertility.

Testicular Trauma:

Severe injury to testes can damage testosterone-producing Leydig cells.

Infections:

Orchitis (testicular inflammation), particularly from mumps in adolescence or adulthood, can damage testes, impairing testosterone production.

Cancer Treatment:

Chemotherapy and radiation therapy, particularly when involving pelvic/testicular area, can permanently damage testes. Testicular cancer treatment (orchiectomy of both testes or radiation) eliminates testosterone production.

Hemochromatosis:

Excess iron storage disease causing iron deposition in testes (and pituitary), damaging both. Hemochromatosis is a common genetic disorder (1 in 200-300 people) often undiagnosed until causing complications.

Varicocele:

Enlarged veins in scrotum, present in 15-20% of men. Severe varicoceles may impair testosterone production, though this is controversial—most men with varicoceles have normal testosterone.

Secondary Hypogonadism (Central Hypogonadism)

The hypothalamus or pituitary fails to produce adequate GnRH or LH, so testes don’t receive stimulation to produce testosterone despite being functionally capable. LH is low or inappropriately normal. Causes include:

Obesity:

The most common cause of secondary hypogonadism in otherwise healthy men. Obesity suppresses the HPG axis through multiple mechanisms: aromatase enzyme in fat tissue converts testosterone to estrogen, elevated estrogen suppresses LH production; inflammatory cytokines from visceral fat suppress HPG axis; insulin resistance and leptin resistance affect hypothalamic function. Weight loss raises testosterone—10 kg (22 pounds) weight loss increases testosterone approximately 100 ng/dL.

Type 2 Diabetes and Metabolic Syndrome:

Independent of obesity, diabetes and metabolic syndrome suppress testosterone through insulin resistance, inflammation, and other mechanisms. This creates vicious cycles—diabetes lowers testosterone, low testosterone worsens insulin resistance and diabetes.

Medications:

Opioids: Chronic opioid use (even prescription pain medications) profoundly suppresses the HPG axis, often causing severe testosterone deficiency. The effect is dose-dependent—higher doses cause more suppression. Opioid-induced hypogonadism affects 50-85% of men on chronic opioids.

Glucocorticoids (Steroids): Prednisone, dexamethasone, and other corticosteroids suppress the HPG axis.

Anabolic Steroids: Exogenous testosterone and anabolic steroids suppress the body’s own testosterone production through negative feedback, sometimes causing permanent hypogonadism after discontinuation.

Other medications: Some antipsychotics, antidepressants, antifungals (ketoconazole), chemotherapy agents.

Pituitary Tumors (Adenomas):

Benign pituitary tumors can directly damage gonadotroph cells that produce LH/FSH or cause compression of normal pituitary tissue, impairing LH production. Prolactin-secreting tumors (prolactinomas) are particularly important—elevated prolactin suppresses GnRH, reducing LH and testosterone.

Other Pituitary Disorders:

Pituitary surgery, radiation, trauma (head injury), Sheehan syndrome (postpartum pituitary infarction, rare), infiltrative diseases (sarcoidosis, hemochromatosis, histiocytosis).

Kallmann Syndrome:

Rare genetic condition causing GnRH deficiency from birth, resulting in absent or delayed puberty, infertility, and sometimes anosmia (absent sense of smell). Diagnosis typically in adolescence when puberty doesn’t occur.

Chronic Illness:

Severe chronic diseases (advanced kidney disease, liver cirrhosis, HIV/AIDS, COPD, chronic heart failure) suppress the HPG axis, causing low testosterone. The mechanism involves inflammatory cytokines, malnutrition, and stress hormones. Testosterone often improves with treatment of underlying disease.

Sleep Apnea:

Obstructive sleep apnea suppresses testosterone production, possibly through intermittent hypoxemia, sleep disruption, and increased cortisol. CPAP treatment for sleep apnea can raise testosterone levels.

Stress and Cortisol:

Chronic severe stress and elevated cortisol (whether from external stress or Cushing’s syndrome) suppress the HPG axis.

Mixed or Multifactorial

Many men, particularly older men with obesity, diabetes, and other comorbidities, have combined primary and secondary hypogonadism—both testicular dysfunction and impaired hypothalamic-pituitary function.

---

Diagnosis and Testing for Low Testosterone

Low testosterone diagnosis requires blood testing—symptoms alone are insufficient as they’re nonspecific. Proper testing requires attention to timing, interpretation, and identifying underlying causes.

When to Test for Low Testosterone

Symptom-Based Testing:

Men experiencing symptoms suggestive of low testosterone—particularly decreased libido, erectile dysfunction, unexplained fatigue, reduced muscle mass with increased body fat, or mood changes—should have testosterone checked.

Screening in High-Risk Groups:

Type 2 Diabetes: 30-40% have low testosterone; consider routine screening.

Obesity: Particularly severe obesity (BMI >35), where prevalence approaches 50%.

Chronic Opioid Use: 50-85% develop opioid-induced hypogonadism; routine screening recommended.

Osteoporosis: All men with osteoporosis or low-trauma fractures should have testosterone measured.

Chronic Glucocorticoid Use: Long-term prednisone or other steroid treatment.

HIV Infection: Higher rates of low testosterone, particularly with advanced disease.

Pituitary Disorders: Known pituitary tumors or pituitary surgery/radiation.

Infertility: Part of male fertility evaluation.

Universal Screening Not Recommended:

Major endocrine societies do not recommend routine testosterone screening in asymptomatic men without risk factors, due to lack of evidence that screening improves outcomes and concerns about overdiagnosis/overtreatment.

Blood Tests for Testosterone

Total Testosterone:

The primary screening test. Measures all three forms (free, albumin-bound, SHBG-bound). Should be measured on two separate occasions (different days) before diagnosing hypogonadism, as testosterone levels fluctuate.

Timing Is Critical:

Testosterone has diurnal variation—highest in early morning (7-10 AM), declining 20-30% by evening. Blood draw should occur between 7-11 AM, ideally 7-9 AM. Afternoon or evening testing may yield falsely low values. This diurnal pattern diminishes with age—older men have less pronounced morning peaks.

Normal Ranges:

Testosterone reference ranges vary by laboratory and age. A common range is 300-1,000 ng/dL (10.4-34.7 nmol/L), though some labs use 264-916 ng/dL.

Diagnosis Threshold:

Most guidelines define low testosterone as total testosterone <300 ng/dL on two morning tests in men with symptoms. However, thresholds are somewhat arbitrary—some symptomatic men have levels 300-400 ng/dL and respond to treatment.

Free Testosterone:

Measures only unbound (biologically active) testosterone. Free testosterone can be directly measured (expensive, technically difficult, often inaccurate except in specialized labs using equilibrium dialysis) or calculated from total testosterone and SHBG (preferred method in most clinical settings).

Free testosterone is particularly useful when SHBG is abnormal:

• High SHBG (aging, hyperthyroidism, liver disease, estrogen): Total testosterone may be normal but free testosterone low (symptomatic)
• Low SHBG (obesity, metabolic syndrome, hypothyroidism): Total testosterone may be low but free testosterone normal or only mildly low (often asymptomatic or minimally symptomatic)

Normal free testosterone: Typically >50-70 pg/mL, though reference ranges vary.

Bioavailable Testosterone:

Free testosterone plus albumin-bound testosterone (both forms available to tissues). Rarely measured directly but can be calculated. Some experts consider bioavailable testosterone more accurate than free testosterone.

Additional Hormone Testing:

If testosterone is confirmed low, additional tests identify the cause and type of hypogonadism:

LH and FSH:

Elevated LH/FSH + low testosterone = primary hypogonadism (testicular failure; testes not responding to pituitary stimulation)

Low or inappropriately normal LH/FSH + low testosterone = secondary hypogonadism (hypothalamic or pituitary dysfunction; inadequate stimulation of normal testes)

Prolactin:

Elevated prolactin (>20 ng/mL) suppresses testosterone. If prolactin is high, pituitary MRI evaluates for prolactinoma.

Estradiol:

Sometimes measured to assess testosterone-to-estrogen ratio and aromatase activity, particularly in obese men. High estradiol from excess aromatization in fat tissue suppresses LH.

SHBG:

Measured to calculate free testosterone. Also provides insight into metabolic status—low SHBG indicates insulin resistance/metabolic syndrome.

Other Tests Based on Clinical Suspicion:

Iron studies: Screen for hemochromatosis if clinical suspicion

Karyotype: If Klinefelter syndrome suspected (small, firm testes, tall stature, gynecomastia, very low testosterone with elevated LH/FSH)

Pituitary MRI: If secondary hypogonadism with very low LH, headaches, visual changes, or elevated prolactin

Semen analysis: If fertility concerns

Metabolic Evaluation

Given the strong metabolic associations, men with low testosterone should be screened for:

• Fasting glucose and HbA1c: Diabetes screening
• Lipid panel: Cholesterol, triglycerides
• BMI and waist circumference: Assess obesity
• Blood pressure

Prostate Evaluation

Before initiating testosterone therapy:

• Prostate-Specific Antigen (PSA): Baseline measurement
• Digital rectal examination: Assess prostate size and detect nodules

Testosterone replacement is contraindicated with prostate cancer, though newer data suggests testosterone doesn’t cause prostate cancer.

Hematocrit

Baseline measurement before TRT, as testosterone increases red blood cell production, sometimes excessively (erythrocytosis).

---

Treatment of Low Testosterone

Treatment goals include restoring normal testosterone levels, alleviating symptoms, improving quality of life, and potentially improving metabolic health. Treatment is individualized based on cause, severity, patient preferences, and treatment goals (fertility vs. symptom relief).

When to Treat

Testosterone replacement therapy (TRT) is indicated for men with:

• Consistently low testosterone (<300 ng/dL on two morning tests)
• Symptoms attributable to low testosterone
• No contraindications (see below)

Symptomatic men with testosterone 300-400 ng/dL (borderline low) may benefit from trial of TRT if other causes of symptoms excluded.

Asymptomatic men with low testosterone generally don’t require treatment unless other indications exist (osteoporosis, unexplained anemia).

Contraindications to Testosterone Replacement

Absolute Contraindications:

• Prostate cancer or high suspicion for prostate cancer
• Breast cancer in men (rare but testosterone-driven)
• Desire for fertility (testosterone suppresses sperm production; see fertility preservation section)
• Uncontrolled heart failure
• Untreated severe sleep apnea
• Hematocrit >54% (excessive red blood cells)

Relative Contraindications (require careful consideration and monitoring):

• Significant lower urinary tract symptoms (LUTS) from benign prostatic hyperplasia
• Elevated PSA without prostate cancer diagnosis
• History of cardiovascular event (myocardial infarction, stroke) in past 6 months
• Significant untreated obstructive sleep apnea

Testosterone Replacement Options

Multiple TRT formulations exist, each with advantages and disadvantages. Choice depends on patient preference, cost, insurance coverage, ability to perform injections, and tolerance.

Intramuscular Injections:

Testosterone Cypionate or Enanthate (Long-Acting Esters):

Injected deep intramuscularly (typically gluteal or thigh muscle) every 1-2 weeks. Dose: 50-100 mg weekly or 100-200 mg every 2 weeks.

Advantages:

• Highly effective
• Inexpensive (especially compounded or generic preparations)
• Relatively convenient (weekly or biweekly dosing)
• Patient or partner can learn self-injection (simple technique)

Disadvantages:

• Injection discomfort (though minimal with proper technique)
• Testosterone levels fluctuate—peak 2-3 days after injection, trough before next dose, causing some men to experience “roller coaster” of mood and energy
• Some men dislike injections

Testosterone Undecanoate (Very Long-Acting Ester):

Brand name Aveed. Injected by healthcare provider every 10-12 weeks after initial loading doses. Much less frequent dosing.

Advantages:

• Infrequent dosing
• More stable testosterone levels than shorter-acting injections

Disadvantages:

• Must be administered by healthcare provider (cannot self-inject) due to risk of rare but serious pulmonary oil microembolism
• More expensive
• Less flexible dosing adjustment

Topical Gels:

Daily application of testosterone gel to skin (typically shoulders, upper arms, abdomen). Examples: AndroGel, Testim, Fortesta, Vogelxo.

Advantages:

• Non-invasive
• Daily application mimics natural testosterone production rhythm somewhat
• Steady testosterone levels without peaks/troughs
• Easy dose adjustment

Disadvantages:

• Daily application required (compliance issue for some)
• Skin irritation in some men
• Risk of transfer to partners/children through skin contact (require precautions: apply to areas covered by clothing, wash hands after application, avoid contact for several hours)
• More expensive than injections
• Variable absorption between individuals

Transdermal Patches:

Testosterone patch applied daily to skin (back, abdomen, thighs, upper arms). Worn 22-24 hours, replaced daily.

Advantages:

• Non-invasive
• Once-daily application
• Provides relatively steady testosterone levels

Disadvantages:

• Skin irritation (30-60% of users develop skin reactions at application site)
• Patches sometimes fall off
• Visible (cosmetic concern for some)
• More expensive

Subcutaneous Pellets:

Testosterone pellets (Testopel) implanted subcutaneously (usually upper buttocks/hip area) through small incision in office procedure under local anesthesia. Pellets slowly release testosterone over 3-6 months.

Advantages:

• Longest duration—typically 3-6 months between procedures
• No daily application or frequent injections
• Steady testosterone levels
• Excellent for men who struggle with compliance

Disadvantages:

• Minor surgical procedure with small infection/extrusion risk
• Once implanted, cannot easily adjust dose if side effects occur
• Expensive
• Pellets sometimes extrude (come out through skin)
• Requires office visit for each insertion

Oral Testosterone:

Testosterone Undecanoate (Jatenzo, Tlando, Kyzatrex):

Oral capsules taken twice daily with food. Recent formulations overcome previous limitations of oral testosterone (liver toxicity, poor absorption).

Advantages:

• Oral administration (most convenient for some men)
• Twice-daily dosing provides steady levels
• No transfer risk to others

Disadvantages:

• Twice-daily dosing (compliance)
• Must be taken with fatty meal for absorption
• Expensive
• Less long-term safety data than other formulations
• Slight elevations in blood pressure in some men

Nasal Gel:

Natesto nasal gel applied inside nostrils three times daily.

Advantages:

• No transfer risk
• Easy application

Disadvantages:

• Three times daily application (poor compliance)
• Nasal irritation
• Expensive
• Inconvenient dosing frequency

Monitoring During Testosterone Replacement

Regular monitoring ensures efficacy, identifies side effects, and prevents complications:

Testosterone Levels:

Check 3-6 months after starting TRT, then annually if stable. Target: mid-normal range (450-600 ng/dL for total testosterone).

For injections: Measure mid-cycle (e.g., day 3-4 of weekly injections) to assess average levels, not peak or trough.

For gels/patches: Measure any time, as levels are relatively stable.

Hematocrit:

Check 3-6 months after starting, then annually. Testosterone stimulates red blood cell production, sometimes excessively. Target: <54%. If >54%, reduce testosterone dose or consider phlebotomy (blood donation).

PSA and Prostate Examination:

Baseline, 3-6 months, then annually. Testosterone doesn’t cause prostate cancer but may accelerate growth of existing cancer. Guidelines recommend stopping TRT if:

• PSA rises >1.4 ng/mL within one year
• PSA rises >0.4 ng/mL per year after first year
• Abnormal digital rectal examination
• Concerning symptoms

Recent evidence suggests these recommendations may be overly cautious—testosterone likely doesn’t significantly increase prostate cancer risk even in men with treated prostate cancer, but controversy persists.

Lipid Panel, Glucose, Liver Function:

Annually. Testosterone may improve or have neutral effects on lipids and glucose. Oral testosterone may affect liver enzymes.

Symptom Assessment:

Regularly assess symptom improvement—libido, erectile function, energy, mood, muscle strength. If symptoms don’t improve despite normalized testosterone, consider other causes or contributing factors.

Bone Density:

If osteoporosis was present, repeat DEXA scan 1-2 years after starting TRT to assess improvement.

Natural Testosterone Optimization (Without TRT)

For men with borderline low testosterone (300-400 ng/dL) or mild symptoms, or those preferring to avoid medication, lifestyle interventions can raise testosterone naturally:

Weight Loss:

Most impactful intervention for overweight/obese men. Every 10 kg (22 pounds) lost increases testosterone approximately 100 ng/dL. Weight loss particularly effective in obese men with secondary hypogonadism.

Exercise:

Resistance Training: Particularly effective—heavy compound movements (squats, deadlifts, bench press) acutely raise testosterone and over time optimize baseline levels. 3-4 resistance training sessions weekly recommended.

High-Intensity Interval Training (HIIT): Short bursts of intense exercise may boost testosterone more than steady-state cardio.

Avoid Overtraining: Excessive endurance exercise (marathon training, extreme cycling) can lower testosterone through chronic stress and low body fat.

Sleep Optimization:

Testosterone production occurs primarily during sleep. Sleep deprivation dramatically lowers testosterone—restricting sleep to 5 hours nightly for one week reduces testosterone by 10-15%. Aim for 7-9 hours quality sleep nightly.

Stress Reduction:

Chronic stress elevates cortisol, which suppresses testosterone. Stress management techniques (meditation, yoga, counseling) may help optimize testosterone.

Nutritional Optimization:

Adequate Healthy Fats: Very low-fat diets (<20% of calories from fat) lower testosterone. Include sources of healthy fats: olive oil, avocados, nuts, fatty fish.

Sufficient Protein: 1.2-1.6 g/kg body weight daily supports muscle maintenance and hormonal health.

Micronutrients: Vitamin D (if deficient), zinc, magnesium support testosterone production. Supplementation raises testosterone only if deficient.

Avoid excessive alcohol: Heavy alcohol consumption suppresses testosterone production.

Avoid Endocrine Disruptors:

BPA (plastics), phthalates (fragrances, personal care products), and other chemicals may interfere with testosterone. Minimize plastic food storage, choose BPA-free containers, limit processed foods.

Realistic Expectations:

Lifestyle interventions can raise testosterone 10-30%, significant for borderline low levels but insufficient for severely low testosterone requiring TRT.

---

Early Detection and Prevention of Low Testosterone

While age-related testosterone decline cannot be entirely prevented, early recognition of risk factors and symptoms enables timely intervention, preventing years of reduced quality of life and potentially reducing metabolic disease progression.

Who Is at Risk for Low Testosterone?

Age:

Risk increases steadily after age 30-40, though significant variation exists. By age 70-80, approximately 50% of men have low testosterone. However, age alone doesn’t necessitate testing—symptomatic men require evaluation regardless of age.

Obesity:

The strongest modifiable risk factor. Obesity suppresses testosterone through multiple mechanisms. Risk increases dramatically with BMI—men with BMI >35 have 50% prevalence of low testosterone.

Type 2 Diabetes:

30-40% of men with type 2 diabetes have low testosterone, independent of obesity. Diabetes and low testosterone create vicious cycles—each worsens the other.

Metabolic Syndrome:

The cluster of abdominal obesity, high blood pressure, elevated triglycerides, low HDL cholesterol, and elevated glucose strongly associates with low testosterone.

Chronic Opioid Use:

50-85% of men on chronic opioid therapy (prescription pain medications, methadone) develop opioid-induced hypogonadism. Higher doses cause greater suppression.

Glucocorticoid (Steroid) Use:

Chronic prednisone or other corticosteroid treatment suppresses testosterone.

Previous Anabolic Steroid Use:

Past use of anabolic steroids or testosterone for bodybuilding can cause persistent hypogonadism after discontinuation through prolonged suppression of the HPG axis.

Sleep Apnea:

Untreated obstructive sleep apnea suppresses testosterone production.

Chronic Illness:

Advanced kidney disease, liver cirrhosis, HIV/AIDS, COPD, chronic heart failure all associate with low testosterone.

Chemotherapy or Radiation:

Particularly involving testes or pituitary, can cause permanent hypogonadism.

Pituitary Disorders:

Known pituitary tumors, previous pituitary surgery or radiation.

Family History:

Genetic conditions causing low testosterone (Klinefelter syndrome, Kallmann syndrome) run in families.

Early Warning Signs: When to Suspect Low Testosterone

Sexual Changes:

Decreased Libido: Gradual loss of interest in sex, reduced sexual thoughts or fantasies, decreased frequency of desired sexual activity. This is often the earliest symptom noticed by men or partners.

Erectile Difficulties: Difficulty achieving erections, reduced rigidity, loss of morning erections. If erections are absent even with stimulation but morning erections remain, psychological or relationship factors are more likely than low testosterone. If morning erections are also absent, hormonal causes (including but not limited to low testosterone) warrant consideration.

Reduced Spontaneous Erections: Fewer nocturnal and morning erections—a specific indicator of hormonal issues.

Physical Changes:

Unexplained Fatigue: Persistent tiredness despite adequate sleep, reduced stamina, need for more rest, reduced exercise tolerance. When fatigue occurs alongside sexual symptoms and body composition changes, low testosterone is more likely.

Body Composition Changes: Gradual increase in body fat particularly around abdomen (“spare tire”), loss of muscle mass (clothes fit differently, reduced muscle definition), reduced strength despite continued exercise.

Breast Tissue Enlargement: Mild gynecomastia (breast tissue development) in some men with low testosterone, though this can have many causes.

Reduced Body Hair: Gradual thinning or loss of body hair, reduced beard growth, decreased need for shaving. This is a late sign occurring with severe, longstanding testosterone deficiency.

Psychological Changes:

Mood Changes: Increased irritability, feeling “on edge,” sadness, loss of enjoyment in activities, reduced motivation and drive.

Cognitive Changes: Difficulty concentrating, memory problems, mental fog, reduced mental sharpness.

These Symptoms Alone Don’t Diagnose Low Testosterone:

All symptoms are nonspecific—many conditions cause fatigue, erectile dysfunction, mood changes, weight gain. However, the constellation of sexual symptoms (particularly decreased libido), body composition changes (loss of muscle, gain of fat), and persistent fatigue, especially in men with risk factors (obesity, diabetes, age >40), warrants testosterone evaluation.

The Importance of Laboratory Testing for Early Detection

Why Symptoms Alone Are Insufficient:

Symptoms of low testosterone overlap extensively with depression, hypothyroidism, sleep disorders, stress, relationship problems, chronic illness, and medications. Additionally, some men with low testosterone are asymptomatic or minimally symptomatic, particularly if decline is gradual. Blood testing is essential for diagnosis.

When Testing Is Recommended:

Symptomatic Men:

Any man experiencing symptoms suggestive of low testosterone—particularly decreased libido, erectile dysfunction, unexplained fatigue, or body composition changes—should have morning testosterone measured.

High-Risk Screening:

Type 2 Diabetes: Consider screening all men with diabetes given 30-40% prevalence and bidirectional relationship.

Severe Obesity: BMI >35, where prevalence approaches 50%.

Chronic Opioid Use: Routine screening recommended given 50-85% prevalence.

Osteoporosis or Low-Trauma Fractures: Testosterone evaluation is part of osteoporosis workup in men.

Infertility: Testosterone and complete hormone panel are standard in male fertility evaluation.

Essential Testing Components:

Two Morning Measurements: Total testosterone checked on two separate mornings (7-11 AM, ideally 7-9 AM). Single measurement insufficient due to testosterone fluctuation.

Free Testosterone or SHBG: Particularly important in obese men, older men, or when total testosterone is borderline (300-400 ng/dL).

LH and FSH: If testosterone is low, these distinguish primary from secondary hypogonadism and guide treatment approach.

Prolactin: If secondary hypogonadism, to evaluate for prolactinoma.

Metabolic Panel: Given strong metabolic associations—glucose, HbA1c, lipids.

The Value of Early Detection:

Symptom Relief: TRT typically improves libido, erectile function, energy, and mood within 3-6 months, dramatically improving quality of life.

Metabolic Benefits: Testosterone replacement may improve insulin sensitivity, reduce visceral fat, improve lipids, though effects on hard cardiovascular outcomes remain unclear.

Bone Health: TRT increases bone density in men with osteoporosis, reducing fracture risk.

Muscle Mass and Strength: TRT increases muscle mass and strength, improving functional capacity, particularly in older men.

Prevention of Progression: For men with borderline low testosterone and risk factors (obesity, metabolic syndrome), early lifestyle interventions (weight loss, exercise) can raise testosterone naturally, potentially preventing progression to levels requiring TRT.

Cost-Effectiveness:

Testosterone testing is inexpensive ($30-60 for total testosterone). Identifying and treating low testosterone prevents years of reduced quality of life, may improve metabolic health, and in older men may reduce frailty and functional decline. The cost of missed diagnosis—years of fatigue, sexual dysfunction, metabolic progression—exceeds testing costs.

What Can Be Prevented or Modified

Primary Prevention (Preventing Low Testosterone Development):

Complete prevention isn’t possible—aging and genetic factors are unavoidable. However, modifiable factors reduce risk:

Maintain Healthy Weight: The single most important modifiable factor. Obesity dramatically increases low testosterone risk. Weight maintenance through diet and exercise preserves testosterone production.

Regular Exercise: Particularly resistance training, optimizes testosterone levels throughout life. Avoid overtraining (excessive endurance exercise).

Adequate Sleep: 7-9 hours nightly supports healthy testosterone production.

Avoid Chronic Opioids When Possible: Work with healthcare providers on non-opioid pain management strategies when feasible.

Minimize Endocrine Disruptor Exposure: Reduce BPA, phthalates, pesticides through dietary choices and product selections.

Manage Chronic Diseases: Optimal diabetes control, treating sleep apnea, managing liver/kidney disease may preserve testosterone levels.

Secondary Prevention (Early Detection and Intervention):

Since complete prevention is impossible, early detection enables timely intervention:

Regular Screening in High-Risk Groups: Men with diabetes, severe obesity, chronic opioids should have testosterone checked even if minimally symptomatic.

Prompt Evaluation of Symptoms: Don’t dismiss sexual symptoms, fatigue, or body composition changes as “normal aging”—seek evaluation.

Lifestyle Intervention for Borderline Low Testosterone: Men with testosterone 300-400 ng/dL can often raise levels through weight loss, exercise, sleep optimization, avoiding TRT.

Tertiary Prevention (Preventing Complications of Low Testosterone):

Once diagnosed:

Testosterone Replacement: Prevents progression of symptoms, improves quality of life, may prevent metabolic complications.

Treating Reversible Causes: If low testosterone is from obesity, medications, or treatable conditions, addressing root causes may restore testosterone without TRT.

Metabolic Monitoring: Regular screening for diabetes, cardiovascular disease, osteoporosis enables early intervention reducing complications.

---

Living With Low Testosterone

For men diagnosed with low testosterone, whether treated or not, understanding the condition, realistic expectations, and long-term management are essential.

Realistic Expectations for Testosterone Replacement

What TRT Does Well:

Sexual Function: 60-80% of men experience improved libido within 3-6 months. Erectile function improves in 50-70% when low testosterone is contributing factor, though men with vascular or neurologic ED may not improve. Improvement may take 3-6 months.

Energy and Mood: 60-80% report improved energy, motivation, and mood within 2-3 months. Effects on depression are variable—some men have dramatic improvement, others minimal change.

Muscle and Body Composition: Muscle mass increases 2-5 kg over 6-12 months with TRT, particularly when combined with resistance training. Fat mass decreases modestly (1-3 kg). Changes occur gradually over 6-12 months.

Bone Density: Increases 3-5% over 1-2 years in men with osteoporosis, reducing fracture risk.

What TRT Doesn’t Reliably Do:

Dramatic Weight Loss: TRT alone causes modest fat loss (typically 1-3 kg). Significant weight loss requires diet and exercise; TRT may make this easier by improving energy and motivation.

Athletic Performance in Normal Testosterone Range: Men with normal baseline testosterone don’t gain athletic advantage from TRT bringing levels to mid-normal range (though supraphysiologic doses, which are inappropriate, do enhance performance—hence anabolic steroid abuse in sports).

Cure Erectile Dysfunction: If ED is primarily vascular (atherosclerosis, diabetes-related vascular damage), low testosterone may be a minor contributing factor. PDE5 inhibitors (Viagra, Cialis) often still needed.

Reverse Cognitive Decline: Effects on cognition are modest and inconsistent. TRT isn’t Alzheimer’s treatment.

Side Effects and Risks of TRT

Common Side Effects (Usually Manageable):

Acne: Increased oil production causes or worsens acne in 10-20% of men. Usually manageable with topical treatments.

Oily Skin: More sebum production.

Gynecomastia (Breast Enlargement): Occurs in 5-10% of men on TRT as some testosterone converts to estrogen via aromatase. Managed by dose reduction or adding aromatase inhibitor if bothersome.

Testicular Shrinkage: Testes shrink 10-25% as exogenous testosterone suppresses LH, and testes no longer produce testosterone. This is expected and not harmful unless fertility desired.

Infertility: TRT suppresses sperm production in 90-95% of men, causing infertility. Effects are usually reversible upon discontinuation but may take 6-12+ months to recover. Men desiring future fertility shouldn’t use TRT (see fertility preservation).

Fluid Retention: Mild ankle swelling in some men, usually mild and transient.

Less Common But Important:

Erythrocytosis (Elevated Red Blood Cells): 5-20% of men develop hematocrit >54%, increasing blood viscosity and possibly increasing stroke risk. Managed by dose reduction, phlebotomy, or temporarily discontinuing TRT.

Sleep Apnea: TRT may worsen untreated sleep apnea or unmask previously undiagnosed sleep apnea. Men with obesity or risk factors should be screened.

Prostate Effects: TRT increases PSA and prostate volume in some men. While testosterone likely doesn’t cause prostate cancer, effects on existing undiagnosed cancer remain debated. Regular PSA monitoring and prostate examination recommended.

Cardiovascular Controversy:

Whether TRT increases cardiovascular risk remains hotly debated. Early studies showed conflicting results—some suggested increased heart attack/stroke risk, particularly in older men with pre-existing cardiovascular disease; others showed neutral or beneficial effects. Recent large studies (TRAVERSE trial) found no increased cardiovascular risk with appropriately prescribed TRT in men with hypogonadism, though concerns persist in certain populations. Current consensus: TRT is likely safe in appropriately selected men with careful monitoring, but remains contraindicated in men with recent cardiovascular events.

Fertility Preservation

Testosterone replacement suppresses sperm production, causing infertility. Men desiring future fertility should NOT use standard TRT. Options include:

Human Chorionic Gonadotropin (hCG) Monotherapy:

hCG mimics LH, stimulating testes to produce testosterone while maintaining fertility. Injected 2-3 times weekly. Less effective than TRT for raising testosterone but preserves fertility.

hCG Plus Testosterone:

Some men use low-dose testosterone with hCG to maintain both testosterone levels and fertility. Effectiveness varies.

Clomiphene or Enclomiphene:

Selective estrogen receptor modulators that increase LH/FSH production, stimulating endogenous testosterone production while preserving fertility. Effective in secondary hypogonadism. Less effective than TRT for raising testosterone.

Sperm Banking:

Before starting TRT, men who may desire future children should consider banking sperm. After starting TRT, fertility may take 6-12+ months to recover, and permanent infertility occasionally occurs.

Recovery After Stopping TRT:

Most men recover spermatogenesis within 6-12 months after stopping TRT, though some require longer (18-24 months) and occasional reports of permanent infertility exist. Recovery can be facilitated with hCG and/or clomiphene.

Lifelong Management

Low testosterone is typically chronic, particularly age-related hypogonadism. Most men who start TRT continue indefinitely, as stopping returns testosterone to low levels and symptoms return. This is not dependency or addiction—it’s hormone replacement for deficiency, analogous to thyroid hormone replacement for hypothyroidism or insulin for diabetes.

Regular monitoring (annually at minimum) ensures treatment remains safe and effective. If lifestyle changes (significant weight loss) occur, testosterone dose may need reduction or occasional men can discontinue TRT while maintaining normal levels.

---

Low testosterone is a common, underdiagnosed condition with significant impacts on sexual function, energy, body composition, metabolic health, and quality of life. Early detection through blood testing in symptomatic men or high-risk groups enables effective treatment with testosterone replacement therapy, improving symptoms and potentially reducing metabolic disease progression. With appropriate monitoring, TRT is safe and highly effective for most men with true hypogonadism.